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Abstract
Previously, embryonic growth has been assumed to be uniform, but in recent years, it has become more clear that genetic and
environmental factors may influence the intrauterine environment and therefore embryonic growth trajectories as well as
pregnancy course and outcome. The objective of this study was to investigate associations between modifiable maternal nutrition
and lifestyle factors during the periconception period and embryonic growth. We established a prospective cohort including 342
women less than 13 weeks pregnant. At enrollment, women filled out a questionnaire regarding demographic and medical data
and a validated food frequency questionnaire. Participants received multiple 3-dimensional ultrasound examinations up until the
12th week of pregnancy, and crown–rump length (CRL) and embryonic volume (EV) were measured offline using V-Scope Virtual
Reality software (version 1.0.0) in a Barco I-Space. Associations between maternal periconception vegetable and fruit intake, folic
acid supplement use, smoking, and alcohol consumption and embryonic growth measurements were assessed by linear mixed
models adjusted for potential confounders. No or postconception initiation of folic acid supplement use was significantly asso-
ciated with a 0.76 mm (7.8%) and 1.63 mm (3.7%) smaller CRL and a 0.01 cm3 (19.5%) and 0.86 cm3 (12.2%) smaller EV at
7þ0 and 11þ0 weeks of gestation, respectively. Smoking, alcohol consumption, and inadequate fruit and vegetable intake showed
weaker associations with embryonic growth parameters. These results emphasize the influence of periconceptional maternal folic
acid supplement use on embryonic growth. Results regarding maternal nutrition and lifestyle factors also suggest an association
with embryonic growth, but this has to be confirmed in a larger study.
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Introduction
Early embryonic growth has traditionally been assumed to be
uniform among humans, but in the past decade, subtle differ-
ences in embryonic growth trajectories have been shown.1-3
These differences not only concern embryonic development
but are also suggested to predict a poor pregnancy course and
outcome.4 Embryonic development and growth is under the
constant influence of the intrauterine environment, which is
determined not only by genetic factors but also by parental
environmental and lifestyle factors, of which most are modifi-
able.5,6 In high-income countries, unhealthy lifestyle (includ-
ing unhealthy nutrition) is an increasing problem.7 A shift
toward behavioral changes, resulting in high caloric intake,
vitamin deficiencies, smoking, alcohol consumption, and phys-
ical inactivity, is causing an increasing prevalence of obesity
and other noncommunicable diseases.8,9
Unfortunately, the high frequency of unhealthy lifestyle is also
present among women of reproductive age, even in those under-
going fertility treatment, despite the known negative effects on
fetal growth and pregnancy outcome and the health ofmother and
child later in life.10 For example, maternal smoking, alcohol con-
sumption, and nutritional deficiencies are associated with fetal
growth restriction and increased risks of miscarriage and fetal
death.11-14 In the long term, unhealthymaternal lifestyle increases
the risk of cardiovascular andmetabolic disease in offspring.15-18
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We hypothesize that increased fruit and vegetable intake
and folic acid supplement use during the vulnerable pericon-
ception period (ie, the 14 weeks before and 10 weeks after
conception) are positively associated with embryonic growth,
whereas smoking and alcohol consumption are negatively asso-
ciated. These 5 nutrition and lifestyle factors are not only
known to affect fertility, they are also easy to address for a
clinician and easy to (self-)report for a patient. Therefore, the
aim of this study was to investigate associations between these
5 modifiable maternal periconception lifestyle risk factors and
first trimester embryonic growth, making use of the novel state-
of-the-art techniques of 3-dimensional ultrasound (3D-US)
combined with the virtual reality technology of the Barco
I-Space.19-21
Participants and Methods
Study Population
This study was part of the Rotterdam Periconception Cohort
(PREDICT study), an ongoing prospective tertiary hospital-
based study embedded in the outpatient clinic of the Depart-
ment of Obstetrics and Gynecology of the Erasmus MC,
UniversityMedical Centre Rotterdam,Rotterdam, theNetherlands.
Adetailedcohortdescriptionhaspreviouslybeenpublished.22From
November 2010 to December 2014, women of at least 18 years of
age who were less than 13 weeks pregnant with a singleton preg-
nancy were eligible for participation.
Data Collection
All pregnancies that were conceived spontaneously or through
intrauterine insemination, semen donation, and hormone ther-
apy were considered to be spontaneous in comparison with
pregnancies conceived through in vitro fertilization (IVF) or
intracytoplasmic sperm injection (ICSI). Pregnancies were
dated as described previously.22 In short, gestational age
(GA) was either based on the last menstrual period in sponta-
neous pregnancies or on the conception date in IVF and ICSI
pregnancies. To obtain information on demographic character-
istics and 5 periconception lifestyle factors (ie, vegetable
intake, fruit intake, folic acid supplement use, smoking, and
alcohol consumption), participants completed a self-
administered questionnaire at enrollment, together with a vali-
dated semi-quantitative food frequency questionnaire, which
was verified for completeness and consistency by the
researcher or research nurse at study entry.22,23
Adequate daily fruit and vegetable intake was defined
according to Dutch guidelines as 2 pieces of fruit (equivalent
to 200 g) and 200 g of vegetables, respectively. Folic acid
supplement use of 400 mg/d is recommended during the peri-
conception period (ie, from 4 weeks prior to conception up to
8 weeks after conception).24,25 Therefore, preconception initia-
tion of folic acid supplement use was defined as adequate,
whereas no or postconception initiation of folic acid supple-
ment use was defined as inadequate. Total abstinence of
smoking and alcohol consumption during the periconception
period was considered adequate. Anthropometrics (ie, maternal
blood pressure, weight, and height) were measured at study
entry by a research nurse.
From November 2010 to December 2012, participants
received weekly transvaginal 3D-US scans from enrollment
up to week 12 of gestation (range: 6þ0 to 12þ6 weeks) by
experienced sonographers. From the end of 2012 onwards, the
number of scans was reduced to 3, performed in the 7th, 9th,
and 11th week of gestation, as the pilot study showed that 3
scans are sufficient to accurately model embryonic growth
curves.2,26 Obtained 3D-US data sets were transferred to the
Barco I-Space (a Cave Automatic Virtual Environment–like
virtual reality system) to create an interactive virtual reality
hologram. Trained researchers performed offline measure-
ments using the I-Space and V-Scope software (version
1.0.0). Crown–rump length (CRL) was measured 3 times, and
the mean of these measurements was used for analysis.
Embryonic volume (EV) measurements were performed once
using a semi-automatic method based on gray levels.27
Statistical Analysis
General characteristics of the study sample and source popula-
tion were compared using Mann-Whitney U tests (for contin-
uous variables) or w2 tests (for categorical variables). To take
into account the correlation between measurements of the same
pregnancy, linear mixed models were used to assess associa-
tions between adequate periconception maternal lifestyle and
embryonic growth. A square root transformation of CRL and
third root transformation of EV data led to linearity with GA
and a constant variance independent of GA and were therefore
used in the analysis.
In the first model, we adjusted for GA only to increase the
precision of the measurements. In the second model, we addi-
tionally adjusted for maternal age, body mass index (BMI),
ethnicity, educational level, parity, and mode of conception.
In the final model, we also adjusted for folic acid supplement
use, fruit intake, vegetable intake, alcohol consumption, and
smoking (all dichotomous; adequate or inadequate) to investi-
gate the independent effects of the lifestyle factors. In all mod-
els, embryonic growth rates for both CRL and EV were
calculated by including an interaction term between the GA
and the 5 risk factors of interest.
P values below .05 were considered statistically significant.
All analyses were performed using IBM SPSS Statistics
version 21.0 for Windows.
Ethical Approval
All data were anonymously processed. This study was con-
ducted according to the guidelines laid down in the Declaration
of Helsinki, and all procedures involving patients were
approved by the medical ethical and institutional review board
of the Erasmus MC, University Medical Centre, Rotterdam, the
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Netherlands. Written informed consent was obtained from all
participants at enrollment.
Results
From a total of 723 first trimester pregnancies enrolled in the
PREDICT study between 2010 and 2014, CRL and EV mea-
surements were available for 563 pregnancies. Of these preg-
nancies, 221 were excluded because of the following reasons:
miscarriage, ectopic pregnancies, congenital anomalies, peri-
natal death, twin pregnancies, oocyte donation, pregnancy ter-
mination, irregular menstrual cycle, observed CRL discrepancy
>6 days from expected CRL, missing questionnaires, and with-
drawal (Figure 1). Thus, a total of 342 pregnancies were
included in the analyses.
In these pregnancies, the median number of 3D-US exam-
inations per pregnancy was 4 (range: 1-7), with a median GA at
the first 3D-US examination of 7þ3 weeks (range: 6þ0-12þ2).
This yielded a total of 1443 ultrasounds, of which 1255 (87.0%)
were of sufficient quality to perform CRL measurements and
1116 (77.3%) to perform EV measurements.
Women in our study sample more often conceived through
IVF or ICSI compared with the source population of the PRE-
DICT study (40.9% vs 26.5%, P < .001; Table 1). In the study
sample, nearly all women used a folic acid supplement (n ¼
329, 98.2%) and 278 (83.0%) women started folic acid supple-
ment use preconceptional. A total of 48 (14.2%) women
smoked and 112 (33.2%) consumed alcohol during the pericon-
ception period. Fruits and vegetable intake was inadequate in
162 (52.9%) and 110 (35.9%) women, respectively.
Inadequate folic acid supplement use was significantly
negatively associated with CRL (0.124, 95% confidence
interval [CI]: 0.222 to 0.026) as well as EV (0.059,
95% CI: 0.105 to 0.014; Table 2). Retransformation to the
original scale showed that the CRL of an embryo of a woman
with inadequate folic acid supplement use was on average 0.75
mm (reduction of 7.8%) and 1.63 mm (reduction of 3.7%)
smaller at 7þ0 and 11þ0 weeks of gestation, respectively, com-
pared to a woman with adequate folic acid supplement use
(Figure 2A). In women with inadequate folic acid supplement
use, the EV was on average 0.01 cm3 (reduction of 19.5%) and
0.86 cm3 (reduction of 12.2%) smaller at 7þ0 and 11þ0 weeks
of gestation, respectively (Figure 2B). The interaction between
GA and folic acid supplement use was statistically significant
(P ¼ .03) for EV, indicating that embryonic growth rates dif-
fered between both groups (ie, higher in women who ade-
quately used folic acid supplements; Figure 2B). Smoking as
well as inadequate fruit intake showed comparable negative
associations with CRL and EV, though not statistically signif-
icant (Table 2).
Discussion
In this study, we found a significant negative association
between inadequate maternal folic acid supplement use and
embryonic growth, measured as CRL and EV as well as growth
rate during the first trimester. Maternal smoking and inade-
quate fruit intake showed comparable results, with nearly sig-
nificant negative associations, but alcohol consumption and
vegetable intake revealed no significant associations with
embryonic growth in our study.
Folate is an important substrate used by the 1-carbon meta-
bolism, in which 1-carbon groups are provided to critical pro-
cesses, such as synthesis of DNA and proteins and epigenetic
programming. This B vitamin is particularly known for its role
in the prevention of neural tube defects.17,28 As early preg-
nancy is a critical period with rapid cell division, growth, and
proliferation as well as high responsiveness to external influ-
ences, optimal maternal folate concentrations are crucial. Opti-
mal concentrations are frequently not achieved through regular
dietary folate intake and deficiencies can lead to impaired epi-
genetic programming associated with long-term health conse-
quences.29 This may explain the reduced embryonic size and
growth in women with inadequate folic acid supplement use in
our study. However, our previous studies also showed that very
high levels of maternal folate are associated with reduced
embryonic and cerebellar growth, suggesting there is an opti-
mum maternal folate status for embryonic growth.30,31 Nutri-
tional factors such as fruit and vegetable intake may also
contribute to stable and reversible methylation abnormalities
Figure 1. Flowchart of the study population. CRL indicates crown–rump length.
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and impaired embryonic development, by means of insufficient
supply or reduced uptake of cofactors of the 1-carbon metabo-
lism. However, it is clear that this is only one of several meta-
bolic pathways that are affected by maternal nutrition and as
such influencing embryonic growth.
Longitudinal studies that focus on first trimester embryonic
growth are scarce, but negative associations between maternal
smoking and alcohol consumption and embryonic growth have
been demonstrated.4,26 This can be partly explained by their
known deranging effects on the 1-carbon metabolism but also
by the direct toxic effects of smoking on embryogenesis, pla-
cental development, and function and by the vasoconstrictive
effects of alcohol consumption.32-34
One of the main strengths of this study is the longitudinally
collected ultrasound data (with a median of 4 3D-US scans per
pregnancy) combined with detailed and validated information
regarding lifestyle. Also, offline virtual reality measurements
of these 3D-US images show high reliability by their excellent
inter- and intraobserver agreement.20,27 Another strength of this
study is the exclusion of pregnancies with an unreliable GA,
whereas pregnancy dating is often a strong confounder in studies
on embryonic growth, due to the variation in timing of ovulation
and implantation in spontaneously conceived pregnancies. A
limitation of this exclusion on the other hand is the smaller study
sample and a relatively high percentage of pregnancies con-
ceived through IVF/ICSI, although we did not observe any
differences in association between nutrition and lifestyle and
embryonic growth between both groups (data not shown).
In this study, we have included both high- and low-quality
3D-US images. Explanations for low-quality 3D-US images
could be uterine position, movement of the embryo, and mater-
nal BMI. Although 3D-US and virtual reality provide a more
authentic and detailed view of the developing embryo, per-
forming measurements on low-quality data can be difficult.
In the future, results of separate analyses of high- and low-
quality images could be compared to determine whether the
quality actually influences the results.
Since diet is very complex and consists of a variety of foods
and nutrients, focusing on a single food group, such as fruits or
vegetables, may be less suitable to demonstrate associations
between maternal nutrition and embryonic growth. Thus, it
might be worth considering to study associations between diet-
ary patterns and embryonic growth. However, it will be very
time-consuming in routine clinical practice to determine a
patient’s dietary pattern, while simple food groups, and conse-
quently nutrient deficiencies, are much easier to query and to
report. Our results emphasize the need to inform women who
are contemplating pregnancy of the importance of preconcep-
tion initiation of folic acid supplement use. Taking into account
the high prevalence of inadequate nutrition and lifestyle in the
reproductive population and the previously described associa-
tions between maternal lifestyle and fetal growth and
Table 1. Baseline characteristics of the source population and study sample.
Study Sample (n ¼ 342) Missing Source Population (n ¼ 723) Missing P
Maternal characteristics
Age (years), median (IQR) 32.0 (29.0-35.0) 5 32.0 (28.0-35.0) 6 .278
Ethnicity 3 1 .518
Western, n (%) 291 (85.8) 616 (85.3)
Non-Western, n (%) 48 (14.2) 106 (14.7)
Education 3 9 .953
Low, n (%) 29 (8.6) 68 (10.9)
Intermediate, n (%) 120 (35.4) 256 (35.9)
High, n (%) 190 (56.0) 390 (54.6)
BMI, kg/m2, median (IQR) 24.3 (22.0-27.8) 30 24.6 (22.1-28.5) 52 .371
Nulliparous, n (%) 107 (31.5) 2 224 (31.2) 5 .621
Mode of conception 0 3 <.001
Spontaneous, n (%) 202 (59.1) 529 (73.5)
IVF/ICSI, n (%) 140 (40.9) 191 (26.5)
Periconception nutrition and lifestyle
Fruits, g/day, median (IQR) 211.5 (84.5-232.6) 36 205.0 (85.3-230.5) 77 .532
Inadequate (<200 g), n (%) 162 (52.9) 326 (50.5) .488
Adequate (200 g), n (%) 144 (47.1) 320 (49.5)
Vegetables, g/day, median (IQR) 167.1 (101.5-240.6) 36 162.2 (100.0-233.3) 77 .627
Inadequate (<200 g), n (%) 110 (35.9) 223 (34.5) .663
Adequate (200 g), n (%) 196 (64.1) 423 (65.5)
Initiation folic acid supplement use 7 4 .291
Yes preconception, n (%) 278 (83.0) 564 (78.6)
Yes postconception, n (%) 51 (15.2) 134 (18.7)
No, n (%) 6 (1.8) 17 (2.4)
Smoking, n (%) 48 (14.2) 4 112 (15.7) 11 .519
Alcohol consumption, n (%) 112 (33.2) 5 223 (31.3) 10 .525
Abbreviations: BMI, body mass index; ICSI, intracytoplasmic sperm injection; IQR, interquartile range; IVF, in vitro fertilization; boldface values: <.001.
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5
pregnancy outcomes, preconception care should also focus on
these inadequacies.
In conclusion, inadequate folic acid supplement use is nega-
tively associated with embryonic growth and embryonic
growth rate. We also show that there might be associations
between periconception maternal smoking, alcohol consump-
tion, inadequate fruit and vegetable intake, and impaired
embryonic growth. Further research with larger study samples
of different (general) populations should elucidate the associ-
ation between periconception maternal lifestyle and embryonic
growth, as the next step toward the early identification of preg-
nant women at risk of poor pregnancy course and outcome.
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